Soy formulas are currently indicated for the treatment of infants in the second semester of life with suspected IgE-mediated allergy to cow’s milk. However, some studies onpharmacoeconomics evaluating the impact of food allergy on the health systems of many countries demonstrated that soy formulas are also used, in practice, in patients with non-IgE-mediated allergy to cow’s milk.